PharmiWeb1h
Cellev8 Nutrition Inc (Formerly Preferred Commerce) Clarifies Business Focus and Highlights Benefits of Superoxide Dismutase Supplements
WELLINGTON, FL / ACCESSWIRE / November 14, 2024 / Cellev8 Nutrition Inc (OTC PINK:CELV), formerly known as Preferred Commerce, today issued a statement to clarify its business focus and retract ...
PharmiWeb1h
Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study
KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / November 14, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces ...
PharmiWeb1h
Nitches Inc. Announces InTheZone Labs' Launch on ShareASale, One of the World’s Leading Affiliate Networks
Nitches Inc. (OTC PINK:NICH) proudly announces a significant milestone in its journey toward nationwide expansion: InTheZone Labs, its premium supplement brand, is now live on ShareASale, one of the ...
PharmiWeb1h
2BScientific Limited announces opening of a new European hub in Germany
Kirtlington, Oxfordshire, UK / 14th November 2024 / 2BScientific Limited proudly announces the opening of its first European hub in Munich, Germany, establishing a strong base to service the growing ...
PharmiWeb1h
Marinomed Biotech AG announces unanimous approval of the restructuring plan by creditors
InsolvencyMarinomed Biotech AG announces unanimous approval of the restructuring plan by creditors 14-Nov-2024 / 14:34 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the ...
PharmiWeb1h
Zane Networks Awarded Blanket Purchase Agreement for Health and Human Services' Health IT Alignment Initiative
WASHINGTON, DC / ACCESSWIRE / November 14, 2024 / Zane Networks, LLC, a leader in healthcare transformation services and solutions, has been awarded a Blanket Purchase Agreement (BPA) by the Office of ...
PharmiWeb1h
IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline
POTOMAC, MD / ACCESSWIRE / November 14, 2024 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced its financial results and strategic advancements for the second fiscal ...
PharmiWeb2h
7 Key Steps for Ensuring Responsible AI Use in Recruitment
The integration of AI in life science recruitment is already reshaping hiring processes by offering increased efficiency, ...
PharmiWeb3h
Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform
Combined with Zomedica's eACTH assay, equine veterinarians get same day answers for their PPID and EMS patients ANN ARBOR, MI / ACCESSWIRE / November 14, 2024 / Zomedica Corp. (NYSE American:ZOM) ...
PharmiWeb4h
Neuraxpharm reports another year of sustained growth and international expansion
Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, marked the sixth anniversary since its ...
PharmiWeb4h
Xeltis announces FDA Breakthrough Device Designation for aXessTM and first patient treated in US pivotal trial
Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces that the Center for Devices and Radiological Health (CDRH) ...
PharmiWeb4h
Actimed Therapeutics Announces Professor David Ebsworth to Become Executive Chairman
Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, ...